健康行动过程取向干预提升下颌前移矫治器依从性的随机临床试验方案
BACKGROUND: Obstructive sleep apnoea (OSA) is a sleep-related breathing disorder characterised by the repeated episodic collapse of the upper airway during sleep, resulting in sleep deprivation, giving rise to apnoeas and hypopnoeas.…
要点
- HAPA阶段匹配干预可能改善OSA患者对MAA的依从性。
- 依从性采用MAA内置微传感器客观测量与睡眠日记主观评估。
- 研究计划随访至36个月,评估长期依从性变化。
核心结论
- 该随机临床试验旨在评估HAPA阶段匹配干预对OSA患者MAA治疗依从性的有效性。
主要发现
- 原文未报告研究结果,仅描述研究方案。
关键数值与推荐
- 干预组接受基于HAPA模型的阶段匹配干预,对照组接受常规护理。
- MAA依从性通过MAA内置微传感器和睡眠日记在3、6、18和36个月收集。
- 使用问卷评估风险感知、结果预期、自我效能(SEMSA)、睡眠质量(PSQI和ESS)、生活质量(EQ-5DL)、社会经济和社会支持量表。
临床怎么用
- 原文未报告临床实践建议。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obstructive sleep apnoea (OSA) is a sleep-related breathing disorder characterised by the repeated episodic collapse of the upper airway during sleep, resulting in sleep deprivation, giving rise to apnoeas and hypopnoeas. Based on the severity of OSA, there are two primary treatment modalities, continuous positive airway pressure (CPAP) and mandibular advancement appliances (MAA); both are adherence-dependent. MAA is offered to those with mild to moderate OSA and is prescribed as an alternative to patients intolerable to CPAP. However, adherence to MAA treatment is variable and declines over time. Hence, the current study aims to assess the effectiveness of the stage-matched intervention, the Health Action Process Approach (HAPA), on adherence to MAA in patients with OSA. METHODS: A single-centre randomised clinical trial will be undertaken at Bart's Health NHS Trust. Fifty-six participants with newly diagnosed OSA are planned to be enrolled in the study and randomised to intervention care (IC) and standardised care (SC) groups. Participants in the SC group will receive routine care whilst participants in the IC group will receive the stage-matched intervention, developed using the HAPA model. Data indicating MAA adherence will be collected both objectively and subjectively, from micro-sensors embedded in the MAA design and sleep diaries, respectively at 3, 6, 18 and 36 months. In addition, a range of questionnaires designed to assess risk perception, outcome expectancy, and self-efficacy (SEMSA) and quality of sleep (PSQI and ESS) and life (EQ-5DL), socio-economic and social support scales will be used. DISCUSSION: The currently available treatments for obstructive sleep apnoea depend entirely on the patient's acceptance and use. There are several factors that affect cooperation and wear for example patients' awareness of their condition, social support and psychological behaviour. In addition, mood, such as anxiety, stress, and depression, may affect wear. At the same time, we know that interventions involving more education and behaviour approaches can help patients adapt more easily to some treatments. As a result, the present trial aims to explore the potential role of these factors to maximise treatment success and minimise side effects. TRIAL REGISTRATION: ClinicalTrials.gov NCT04092660 . Registered on September 6, 2019.
引用
- Tallamraju H, Newton JT, Fleming PS, et al. Intervention to enhance adherence to mandibular advancement appliance in patients with obstructive sleep apnoea: study protocol for a randomised clinical trial. Trials. 2021. PMID: 34645490. doi:10.1186/s13063-021-05582-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。